Kim D. Janda,Nicholas T. Jacob,Jonathan W. Lockner
申请号：
US16359633
公开号：
US20190284188A1
申请日:
2019.03.20
申请国别(地区):
US
年份:
2019
代理人:
摘要：
There are disclosed imidazolinopyrimidinone compounds that have activity to induce TRAIL gene expression in macrophages. There is further disclosed a method for treating various cancers comprising administering effective amounts of an imidazolinopyrimidinone having the structure of Formula I herein.
